NO930798D0 - Fremgangsmaate og middel mot tumorer - Google Patents

Fremgangsmaate og middel mot tumorer

Info

Publication number
NO930798D0
NO930798D0 NO930798A NO930798A NO930798D0 NO 930798 D0 NO930798 D0 NO 930798D0 NO 930798 A NO930798 A NO 930798A NO 930798 A NO930798 A NO 930798A NO 930798 D0 NO930798 D0 NO 930798D0
Authority
NO
Norway
Prior art keywords
tumors
medicine
procedure
Prior art date
Application number
NO930798A
Other languages
English (en)
Other versions
NO930798L (no
Inventor
Kohji Egawa
Ichiei Sato
Original Assignee
Bio Defense Inst Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Defense Inst Co Ltd filed Critical Bio Defense Inst Co Ltd
Publication of NO930798D0 publication Critical patent/NO930798D0/no
Publication of NO930798L publication Critical patent/NO930798L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
NO93930798A 1992-03-05 1993-03-04 Fremgangsmaate og middel mot tumorer NO930798L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4048840A JPH05246889A (ja) 1992-03-05 1992-03-05 制癌方法および制癌剤

Publications (2)

Publication Number Publication Date
NO930798D0 true NO930798D0 (no) 1993-03-04
NO930798L NO930798L (no) 1993-09-06

Family

ID=12814449

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930798A NO930798L (no) 1992-03-05 1993-03-04 Fremgangsmaate og middel mot tumorer

Country Status (15)

Country Link
EP (1) EP0563627A2 (no)
JP (1) JPH05246889A (no)
KR (1) KR930019225A (no)
CN (1) CN1079400A (no)
AU (1) AU3398793A (no)
BR (1) BR9300764A (no)
CA (1) CA2090957A1 (no)
CZ (1) CZ34293A3 (no)
FI (1) FI930976A (no)
HU (1) HUT67859A (no)
IL (1) IL104944A0 (no)
NO (1) NO930798L (no)
NZ (1) NZ247057A (no)
SK (1) SK15993A3 (no)
ZA (1) ZA931558B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235525B1 (en) * 1991-05-23 2001-05-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
IT1274592B (it) * 1994-08-05 1997-07-18 Angela Turiano Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
WO1998019167A2 (en) * 1996-10-29 1998-05-07 Fred Hutchinson Cancer Research Center, Inc. Cell stress regulated human mhc class i gene
FR2775189B1 (fr) * 1998-07-24 2001-06-08 Commissariat Energie Atomique Compositions anti-tumorales a base d'antigenes hla-g ou d'anticorps anti-hla-g
JP4470007B2 (ja) * 1998-02-20 2010-06-02 コミサリア・ア・レネルジー・アトミーク Ｈｌａ−ｇを発現する、抗癌治療に感受性な腫瘍を選択する方法およびその使用
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
EP1245675A1 (en) * 2001-03-28 2002-10-02 Kohji Egawa Cancer cell-specific HLA-F antigen and a diagnostic method of cancer by using thereof
WO2004078137A2 (en) * 2003-03-04 2004-09-16 Greenville Hospital System Antitumor agents comprising a targeting portion and an immune response triggering portion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3825615A1 (de) * 1988-07-28 1990-02-01 Behringwerke Ag Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung

Also Published As

Publication number Publication date
SK15993A3 (en) 1993-10-06
HU9300612D0 (en) 1993-05-28
FI930976A0 (fi) 1993-03-04
CZ34293A3 (en) 1994-01-19
IL104944A0 (en) 1993-07-08
AU3398793A (en) 1993-09-09
NZ247057A (en) 1995-10-26
JPH05246889A (ja) 1993-09-24
CA2090957A1 (en) 1993-09-06
ZA931558B (en) 1993-09-27
KR930019225A (ko) 1993-10-18
BR9300764A (pt) 1993-09-28
EP0563627A2 (en) 1993-10-06
CN1079400A (zh) 1993-12-15
HUT67859A (en) 1995-03-23
NO930798L (no) 1993-09-06
FI930976A (fi) 1993-09-06
EP0563627A3 (no) 1994-04-27

Similar Documents

Publication Publication Date Title
NO911720L (no) Fremgangsmaate og innretning for avviksboring.
DK531885D0 (da) Fremgangsmaade til desinfektion og middel dertil
DK0390394T3 (da) Middel og anvendelse deraf
NO931873D0 (no) Fremgangsmaate og system for geometrimaaling
DK0562759T3 (da) Interstitiel røntgennål
DK0660689T3 (da) Osteosyntesehjælpemiddel
FI940699A (fi) Lääkesäiliö
NO176263C (no) Styreinnretning for elektriske rullestoler og lignende
NO863631L (no) Effektive hologrammer og fremgangsmaate for fremstilling derav.
NO870927D0 (no) Fremgangsmaate og anordning for aa redusere magnetiske stroefelt.
DK287188D0 (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
NO930798D0 (no) Fremgangsmaate og middel mot tumorer
NO903038D0 (no) Fremgangsmaate og innretning for kontinuerlig belysning avemner.
NO932386D0 (no) Forprodukt og fremgangsmaate for fremstilling av samme
NO901745L (no) Fremgangsmaate og system for aa gjennomfoere minesveiping.
NO931945D0 (no) Fremgangsmaate og system for signalbehandling
NO885206D0 (no) Anordning og framgangsmŸte for fjerning av strenger.
DK0418004T3 (da) Forebyggende og terapeutisk middel mod hepatitis
NO893474L (no) Flammehemmende midler og fremgangsmaate for anvendelse.
NO891630D0 (no) Fremgangsmaate og anordning for fremstilling av diafragmer.
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
NO884325D0 (no) Fremgangsmaate og anordning for olefinseparasjon.
NO921022D0 (no) Fremdriftsinnretning for rullestol og lignende
NO890087L (no) Fremgangsmaater og blandinger for aa forhindre mavesaar.